CAJ | 학술논문

目的：探讨中药疏肝消脂方治疗非酒精性脂肪肝的疗效及治疗前后肝脏CT影像学差异。方法60例确诊为非酒精性脂肪肝患者随机分为治疗组和对照组，每组30例，对照组患者给予调节饮食结合适当运动进行治疗，治疗组在此基础上服用疏肝消脂方，分析比较治疗后3个月后两组CT、临床及生化指标变化情况。结果治疗组临床治疗总有效率93.33%，对照组86.67%，两组比较差异有统计学意义(P＜0.05)；治疗后，与对照组相比，治疗组ALT、AST、TC及TG等肝功能各项指标均有所改善，差异有统计学意义(P<0.05)；与治疗前比较，治疗组肝CT值及肝/脾CT比值均升高，差异有统计学意义(P<0.05)；治疗后与对照组相比，治疗组肝CT值及肝/脾CT比值均升高，差异有统计学意义(P<0.05)。结论疏肝消脂方治疗非酒精性脂肪肝疗效显著，CT定量技术评估中医药治疗非酒精性脂肪肝疗效方法安全、准确。
목적：탐토중약소간소지방치료비주정성지방간적료효급치료전후간장CT영상학차이。방법60례학진위비주정성지방간환자수궤분위치료조화대조조，매조30례，대조조환자급여조절음식결합괄당운동진행치료，치료조재차기출상복용소간소지방，분석비교치료후3개월후량조CT、림상급생화지표변화정황。결과치료조림상치료총유효솔93.33%，대조조86.67%，량조비교차이유통계학의의(P＜0.05)；치료후，여대조조상비，치료조ALT、AST、TC급TG등간공능각항지표균유소개선，차이유통계학의의(P<0.05)；여치료전비교，치료조간CT치급간/비CT비치균승고，차이유통계학의의(P<0.05)；치료후여대조조상비，치료조간CT치급간/비CT비치균승고，차이유통계학의의(P<0.05)。결론소간소지방치료비주정성지방간료효현저，CT정량기술평고중의약치료비주정성지방간료효방법안전、준학。
Objective To investigate the effect of Shugan Treatment of Nonalcoholic fatty liver and liver CT imaging efficacy differences before and after treatment. Methods 60 cases diagnosed as non-alcoholic fatty liver disease were randomly assigned to a treatment group and a control group of 30 patients, The control group received diet and adequate exercise to adjust for treatment, the treatment group took Shugan Xiaozhi Fang on this basis, Analysied and comparison of the two groups CT, clinical and biochemical indicators of change in three months. Results The treatment group in the total efficiency of 93.33%, 86.67%in the control group, the difference was statistically significant (P<0.05);Compared with the control group, the ALT, AST, TC and TG and other indicators of liver function of treatment group were improved, and the difference was statistically significant (P<0.05);compared with before treatment, the treatment of liver and liver CT value/spleen CT ratio were increased, the difference was statistically significant (P<0.05);After treatment compared with the control group, the treatment of liver and liver CT value/spleen CT ratio were increased, the difference was statistically significant (P<0.05). Conclusion Shugan Xiaozhi Fang treat non-alcoholic fatty liver disease significantly, CT quantitative techniques to assess medical treatment of nonalcoholic fatty liver disease method is safe, accurate.